Medical News

RSS

GI Dynamics' EndoBarrier therapy to treat type 2 diabetes and obesity granted European CE mark approval

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier, a non-surgical therapy to treat type 2 diabetes and obesity. This approval is specific to up to 12 months of treatment with the EndoBarrier; the product has already received CE mark approval for three and six months of treatment. Through its commercial partner, Elemental Healthcare, GI Dynamics has also announced the launch of the EndoBarrier in the United Kingdom.

15 Oct 2010

DAS acquires Excerpta Medica from Elsevier

Diversified Agency Services (DAS), a division of Omnicom Group, announced that it has acquired Amsterdam-based medical communications agency Excerpta Medica from world-leading publisher Elsevier.

15 Oct 2010

Emerging Healthcare anticipates results of FDA-approved human embryonic stem-cell treatment

Emerging Healthcare Solutions, Inc. eagerly anticipates the results of the first FDA-approved human embryonic stem-cell treatment on a patient with spinal cord injuries, which began this week.

15 Oct 2010

Neptune second quarter revenue increases 200% to $4,114,000

Neptune Technologies & Bioressources Inc. today reports its consolidated financial results for the three and six-month periods ended August 31, 2010.

15 Oct 2010

FDA warns companies over unsubstantiated claims of 'chelation' products

The Food and Drug Administration says there's no proof that nonprescription 'chelation' products—which claim to treat everything from autism to Alzheimer's disease—can rid the body of toxic metals.

15 Oct 2010

LifeBridge Health reveals two ways to prevent seasonal flu

You're having that dreaded feeling. Your muscles are aching, you've got a a fever and sore throat . Get ready: It is flu season again! The flu is a respiratory virus that's contagious. In addition to the symptoms above, a, cough and headache, as well as diarrhea may indicate the virus is present.

15 Oct 2010

A new therapeutic approach for cancer

Trials are being organized for a new therapeutic approach to treating cancer, under exclusive license by Viral Genetics, Inc. According to Scott & White Healthcare Senior Vice President for Research Richard E. Beswick, M.D., who is also assistant dean of research at the Texas A&M Health Science Center College of Medicine, the trials will be conducted at the Glenda Tanner Vasicek Cancer Treatment Center, located at Scott & White in Temple, Texas.

15 Oct 2010

Visa supports global law enforcement action against online sale of counterfeit, illegal medicines

Visa Inc. and Visa Europe today announced support for "Operation Pangea III," a global law enforcement action coordinated by INTERPOL targeting the online sale of counterfeit and illegal medicines resulting in arrests across the globe and the seizure of thousands of potentially harmful medicines.

15 Oct 2010

Scientists to monitor effectiveness of Streptococcus vaccine

Respiratory infections and diarrhoeal diseases kill approximately four million children each year, with most deaths occurring in developing countries. New vaccines for Streptococcus pneumoniae, a bacterium that causes pneumonia, and rotavirus, the most common cause of severe diarrhoea, have proved successful in preventing the development of the diseases in clinical trials, but have yet to be used routinely in many parts of Africa.

15 Oct 2010

Questcor, CNF partner to fund infantile spasms research

Questcor Pharmaceuticals, Inc. announced that it is partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms (IS). Catherine Chu-Shore, MD, of Massachusetts General Hospital was selected by CNF as the recipient of this first-ever "Logan Infantile Spasms Research Award."

15 Oct 2010

CIHR, Genome BC announce $5.4 million for microbiome research

The University of British Columbia today welcomed the announcement of $5.4 million in funding from the Canadian Institutes of Health Research (CIHR) and Genome British Columbia for research into how micro-organisms affect human health.

15 Oct 2010

Study highlights need to address overuse, underuse of colorectal cancer screening tests

Only one-fifth of primary care physicians in the US follow practice guidelines for colorectal cancer screening for all the tests they recommend, according to Dr. Robin Yabroff from the National Cancer Institute and her colleagues. About 40 percent followed guidelines for some of the tests they recommended and the remaining 40 percent did not follow guidelines for any of the screening tests they recommended.

15 Oct 2010

Startech, STRCIC invest $2.5 million in ViroXis Corporation

Startech and the South Texas Regional Center of Innovation and Commercialization (STRCIC) today announced the investment of $2.5 million in San Antonio-based ViroXis Corporation by the Texas Emerging Technology Fund (TETF).

15 Oct 2010

GfK HealthCare: RRMS patients anticipate availability of new oral therapies

Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.

15 Oct 2010

Childhood obesity impacts musculoskeletal system

An epidemic of childhood obesity can have a devastating impact on a child's musculoskeletal system, the U.S. Bone and Joint Decade says. Extra weight stresses growing bones, causing pain and interfering with normal growth and development.

15 Oct 2010

Chest compression-only method of CPR better than standard CPR

Heart attack patients whose hearts have stopped beating and who receive cardiopulmonary resuscitation (CPR) from bystanders fare better if their resuscitators skip the rescue breaths and do only chest compression, according to a study led by researchers at Washington University School of Medicine in St. Louis.

15 Oct 2010

Merge Healthcare announces addition of four new customers for etrials myEDC solution

Merge Healthcare, a leading HIT solutions provider, today announced the addition of four new customers for its etrials myEDC solution. These wins reflect continued momentum and interest from the pharmaceutical and contract research organization community with this innovative solution.

15 Oct 2010

Cellectis first half 2010 revenues increase 25%

Cellectis, the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.

15 Oct 2010

ISCO's new joint marketing venture to launch skin care products

International Stem Cell Corporation , and a new firm to be formed by John Mauldin announced today the formation of a new joint marketing venture to launch a line of skin care products developed by ISCO's wholly owned subsidiary, Lifeline Skin Care, Inc. Mauldin, a significant marketing talent, is president of Millennium Wave Investments and author of an economic letter that goes to over 1.5 million readers.

15 Oct 2010

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

15 Oct 2010